Methylomic analysis identifies frequent DNA methylation of Zinc Finger protein 582 (ZNF582) in cervical neoplasms

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Huang, Rui Lan ^a,b,c   Chang, Cheng Chang ^a,c   Su, Po Hsuan ^a,c   Chen, Yu Chih ^a,c   Liao, Yu Ping ^a,c   Wang, Hui Chen ^a,c   Yo, Yi Te ^a,c   Chao, Tai Kuang ^a   Huang, Hsuan Cheng ^b   Lin, Ching Yu ^d   Chu, Tang Yuan ^e   Lai, Hung Cheng ^a,c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 582;

AREA UNDER THE CURVE; ARTICLE; CANCER SCREENING; CERVICAL INTRAEPITHELIAL NEOPLASIA 3; CONTROLLED STUDY; DBC1 GENE; DISEASE SEVERITY; DNA DETERMINATION; DNA METHYLATION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; PDE8B GENE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; ZNF582 GENE;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; BIOLOGICAL MARKERS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; ROC CURVE; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS; ZINC FINGERS;

EID: 84864008379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041060     Document Type: Article

References (55)

1. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, et al. (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet pp. 1461-1484.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
3. Woodman CB, Collins SI, Young LS, (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7: 11-22.
4. Brinton LA, Hamman RF, Huggins GR, Lehman HF, Levine RS, et al. (1987) Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 79: 23-30.
5. Cottrell SE, Laird PW, (2003) Sensitive detection of DNA methylation. Ann N Y Acad Sci 983: 120-130.
6. Hellberg D, Stendahl U, (2005) The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer. Anticancer Res 25: 3041-3046.
7. Wentzensen N, Sherman ME, Schiffman M, Wang SS, (2009) Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 112: 293-299.
8. Ziegler RG, Weinstein SJ, Fears TR, (2002) Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. J Nutr 132: 2345S-2349S.
9. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, et al. (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132: 810-819.
10. Lynge E, Rebolj M, (2009) Primary HPV screening for cervical cancer prevention: results from European trials. Nat Rev Clin Oncol 6: 699-706.
11. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, et al. (2002) Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288: 1749-1757.
12. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, et al. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29: 4294-4301.
13. Koliopoulos G, Chrelias C, Pappas A, Makridima S, Kountouris E, et al. (2012) The diagnostic accuracy of two methods for E6&7 mRNA detection in women with minor cytological abnormalities. Acta Obstet Gynecol Scand.
14. Negri G, Bellisano G, Carico E, Faa G, Kasal A, et al. (2011) Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri. Int J Gynecol Pathol 30: 407-413.
15. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, et al. (2011) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103: 368-383.
16. Silling S, Kreuter A, Hellmich M, Swoboda J, Pfister H, et al. (2012) Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men. J Clin Virol 53: 325-331.
17. Sorbye SW, Fismen S, Gutteberg T, Mortensen ES, (2010) Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing. PLoS One 5: e12724.
18. Tsimplaki E, Argyri E, Michala L, Kouvousi M, Apostolaki A, et al. (2012) Human papillomavirus genotyping and e6/e7 mRNA expression in greek women with intraepithelial neoplasia and squamous cell carcinoma of the vagina and vulva. J Oncol 2012: 893275.
19. Bird A, (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
20. Sharma S, Kelly TK, Jones PA, (2010) Epigenetics in cancer. Carcinogenesis 31: 27-36.
21. Laird PW, (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
22. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, et al. (2008) Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 123: 161-167.
23. Wang SS, Smiraglia DJ, Wu YZ, Ghosh S, Rader JS, et al. (2008) Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res 68: 2489-2497.
24. Lai HC, Lin YW, Huang RL, Chung MT, Wang HC, et al. (2010) Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer 18: 4266-4274.
25. Sova P, Feng Q, Geiss G, Wood T, Strauss R, et al. (2006) Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 15: 114-123.
26. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, et al. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32.
27. Lai HC, Lin YW, Chang CC, Wang HC, Chu TW, et al. (2007) Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecol Oncol 104: 629-635.
28. Reesink-Peters N, Wisman GB, Jeronimo C, Tokumaru CY, Cohen Y, et al. (2004) Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2: 289-295.
29. Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, et al. (2008) Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res 68: 6065-6073.
30. Liu CY, Chao TK, Su PH, Lee HY, Shih YL, et al. (2009) Characterization of LMX-1A as a metastasis suppressor in cervical cancer. J Pathol 219: 222-231.
31. Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, et al. (2007) Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 67: 10163-10172.
32. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41: 178-186.
33. Lim EH, Ng SL, Li JL, Chang AR, Ng J, et al. (2010) Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol 119: 225-231.
34. Chao TK, Ke FY, Liao YP, Wang HC, Yu CP, et al. (2011) Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1). Diagn Cytopathol.
35. Overmeer RM, Louwers JA, Meijer CJ, van Kemenade FJ, Hesselink AT, et al. (2011) Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Int J Cancer 129: 2218-2225.
36. van der Meide WF, Snellenberg S, Meijer CJ, Baalbergen A, Helmerhorst TJ, et al. (2011) Promoter methylation analysis of WNT/beta-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. Gynecol Oncol 123: 116-122.
37. Eijsink JJ, Lendvai A, Deregowski V, Klip HG, Verpooten G, et al. (2011) A four gene methylation marker panel as triage test in hr-HPV positive patients. Int J Cancer.
38. Hesselink AT, Heideman DA, Steenbergen RD, Coupe VM, Overmeer RM, et al. (2011) Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res 17: 2459-2465.
39. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862.
40. Feinberg AP, (2010) Genome-scale approaches to the epigenetics of common human disease. Virchows Arch 456: 13-21.
41. Jacinto FV, Ballestar E, Ropero S, Esteller M, (2007) Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res 67: 11481-11486.
42. Cheung HH, Lee TL, Davis AJ, Taft DH, Rennert OM, et al. (2010) Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br J Cancer 102: 419-427.
43. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, et al. (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 10: 1413-1419.
44. Huntley S, Baggott DM, Hamilton AT, Tran-Gyamfi M, Yang S, et al. (2006) A comprehensive catalog of human KRAB-associated zinc finger genes: insights into the evolutionary history of a large family of transcriptional repressors. Genome Res 16: 669-677.
45. Figueroa ME, Lugthart S, Li Y, Erpelinck-Verschueren C, Deng X, et al. (2010) DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia. Cancer Cell pp. 13-27.
46. Urrutia R, (2003) KRAB-containing zinc-finger repressor proteins. Genome Biol 4: 231.
47. Peng H, Gibson LC, Capili AD, Borden KL, Osborne MJ, et al. (2007) The structurally disordered KRAB repression domain is incorporated into a protease resistant core upon binding to KAP-1-RBCC domain. J Mol Biol 370: 269-289.
48. Habuchi T, Luscombe M, Elder PA, Knowles MA, (1998) Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics 48: 277-288.
49. Gronbaek K, Ralfkiaer U, Dahl C, Hother C, Burns JS, et al. (2008) Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms. Mod Pathol 21: 632-638.
50. Habuchi T, Takahashi T, Kakinuma H, Wang L, Tsuchiya N, et al. (2001) Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer. Oncogene 20: 531-537.
51. Izumi H, Inoue J, Yokoi S, Hosoda H, Shibata T, et al. (2005) Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum Mol Genet 14: 997-1007.
52. Wright KO, Messing EM, Reeder JE, (2004) DBCCR1 mediates death in cultured bladder tumor cells. Oncogene 23: 82-90.
53. Bibikova M, Fan J-B, (2010) Genome-wide DNA methylation profiling. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2: 210-223.
54. Laird PW, (2010) Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 11: 191-203.
55. Cottrell SE, (2004) Molecular diagnostic applications of DNA methylation technology. Clin Biochem 37: 595-604.